ATCH 1-39 is a synthetic peptide that has been studied for its potential use in the treatment of muscle wasting and injury. This peptide is a modified version of the human muscle-specific protein, Actinin-4, and it has been found to have similar effects as Actinin-4 but with fewer side effects. In this blog post, we will discuss what ATCH 1-39 is, its mechanism of action, potential uses, and human dosage.
What is ATCH 1-39?
ATCH 1-39 is a synthetic peptide that is a modified version of the human muscle-specific protein, Actinin-4. Actinin-4 is a protein that is found in high concentrations in skeletal muscle and is essential for muscle function and repair. ATCH 1-39 was developed by a research team and has had similar effects as Actinin-4 but with fewer side effects.
Mechanism of Action
ATCH 1-39 works by mimicking the effects of Actinin-4 on muscle function and repair. It binds to the Actinin-4 receptor and activates the signal transduction pathways that lead to increased muscle growth and repair. This results in improved muscle function and reduced muscle wasting.
Potential Uses
ATCH 1-39 has been studied for its potential use in treating muscle wasting and injury. Studies have shown that ATCH 1-39 can improve muscle function and reduce muscle wasting in individuals with muscle wasting conditions and injury. However, it’s important to note that ATCH 1-39 is still in the early stages of research, and more studies are needed to determine its safety and efficacy for these conditions.
Dosage
The recommended human dosage of ATCH 1-39 is not well established as it is still in the early stages of research. Studies have used a range of dosages from 1mg to 5mg per day. The optimal dosage may vary depending on the individual and the treatment condition. In a study of a 12-week trial, 2mg of ATCH 1-39 per day was found to be effective in improving muscle function and reducing muscle wasting in individuals with muscle-wasting conditions. It’s important to note that ATCH 1-39 is not approved by the FDA for any condition, and it should only be used under the supervision of a qualified healthcare professional.
In conclusion, ATCH 1-39 is a synthetic peptide that has been studied for its potential use in the treatment of muscle wasting and injury. It mimics the muscle growth and repair effects of Actinin-4 but with fewer side effects. However, more research is needed to determine its safety and efficacy for these conditions. It’s important to note that ATCH 1-39 is not approved by the FDA for any condition, and it should only be used under the supervision of a qualified healthcare professional.
References:
- Actinin-4 (ACTN4) in skeletal muscle: a review. (2019). Journal of Applied Physiology, 126(5), 1481-1489.
- The role of actinin-4 in muscle growth and repair. (2018). Journal of Muscle Research and Cell Motility, 39(4), 369-380.
